These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 29604984)

  • 41. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
    Sacktor N
    J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measuring and managing cognitive impairment in HIV.
    Nightingale S; Winston A
    AIDS; 2017 Jun; 31 Suppl 2():S165-S172. PubMed ID: 28471947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau).
    Krut JJ; Price RW; Zetterberg H; Fuchs D; Hagberg L; Yilmaz A; Cinque P; Nilsson S; Gisslén M
    Virulence; 2017 Jul; 8(5):599-604. PubMed ID: 27435879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapy.
    Guerveno C; Raymond S; Metsu D; Gandia P; Izopet J; Martin-Blondel G; Delobel P
    AIDS; 2019 Mar; 33(3):593-594. PubMed ID: 30702524
    [No Abstract]   [Full Text] [Related]  

  • 45. AIDS dementia complex.
    Brew BJ
    Neurol Clin; 1999 Nov; 17(4):861-81. PubMed ID: 10517932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Controversies in HIV-associated neurocognitive disorders.
    Nightingale S; Winston A; Letendre S; Michael BD; McArthur JC; Khoo S; Solomon T
    Lancet Neurol; 2014 Nov; 13(11):1139-1151. PubMed ID: 25316020
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Global developments in HIV neurology.
    Wright EJ; Thakur KT; Bearden D; Birbeck GL
    Handb Clin Neurol; 2018; 152():265-287. PubMed ID: 29604981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments.
    Gray F; Adle-Biassette H; Chretien F; Lorin de la Grandmaison G; Force G; Keohane C
    Clin Neuropathol; 2001; 20(4):146-55. PubMed ID: 11495003
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Encephalopathy in HIV patients on antiretroviral therapy].
    Kishida S
    Rinsho Shinkeigaku; 2015; 55(6):435-6. PubMed ID: 26103821
    [No Abstract]   [Full Text] [Related]  

  • 50. Benefit or toxicity from neurologically targeted antiretroviral therapy?
    Brew BJ
    Clin Infect Dis; 2010 Mar; 50(6):930-2. PubMed ID: 20146628
    [No Abstract]   [Full Text] [Related]  

  • 51. HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment.
    Spudich S; González-Scarano F
    Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a007120. PubMed ID: 22675662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebrospinal fluid inhibitory quotients of antiretroviral drugs in HIV-infected patients are associated with compartmental viral control.
    Calcagno A; Simiele M; Alberione MC; Bracchi M; Marinaro L; Ecclesia S; Di Perri G; D'Avolio A; Bonora S
    Clin Infect Dis; 2015 Jan; 60(2):311-7. PubMed ID: 25281609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Initial suboptimal CD4 reconstitution with antiretroviral therapy despite full viral suppression in a cohort of HIV-infected patients in Senegal.
    Batista G; Buvé A; Ngom Gueye NF; Manga NM; Diop MN; Ndiaye K; Thiam A; Ly F; Diallo A; Ndour CT; Seydi M
    Med Mal Infect; 2015 Jun; 45(6):199-206. PubMed ID: 25907261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HIV-associated central nervous system diseases in the era of combination antiretroviral therapy.
    Tan IL; McArthur JC
    Eur J Neurol; 2011 Mar; 18(3):371-2. PubMed ID: 21159069
    [No Abstract]   [Full Text] [Related]  

  • 55. Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs.
    Bell JE; Arango JC; Anthony IC
    J Neuroimmune Pharmacol; 2006 Jun; 1(2):182-91. PubMed ID: 18040783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Magnetic resonance imaging and spectroscopy of the brain in HIV disease.
    Descamps M; Hyare H; Stebbing J; Winston A
    J HIV Ther; 2008 Sep; 13(3):55-8. PubMed ID: 19039299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nanoformulated Antiretrovirals for Penetration of the Central Nervous System: State of the Art.
    Fiandra L; Capetti A; Sorrentino L; Corsi F
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):17-30. PubMed ID: 27832401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Memory loss in persons with HIV/AIDS: assessment and strategies for coping.
    Selnes OA
    AIDS Read; 2005 Jun; 15(6):289-92, 294. PubMed ID: 15962451
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of lifelong cumulative HIV viremia on long-term recovery of CD4+ cell count and CD4+/CD8+ ratio among patients on combination antiretroviral therapy.
    Seng R; Goujard C; Krastinova E; Miailhes P; Orr S; Molina JM; Saada M; Piroth L; Rouzioux C; Meyer L;
    AIDS; 2015 Mar; 29(5):595-607. PubMed ID: 25715104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nanotechnology applications for improved delivery of antiretroviral drugs to the brain.
    Wong HL; Chattopadhyay N; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):503-17. PubMed ID: 19914319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.